Bill > SB741

This bill expands the practice of pharmacy in Oklahoma by allowing pharmacists to test for and initiate drug therapy for minor, nonchronic health conditions, subject to specific guidelines. Under this legislation, pharmacists can perform tests and start treatment for conditions like influenza, SARS-CoV-2, lice, and other emerging public health threats, but only when operating under a standing order from a licensed physician or medical director. The tests must be FDA-approved or authorized under emergency use authorization and must be waived under the Clinical Laboratory Improvement Amendments (CLIA) or deemed CLIA-waived. An important limitation is that pharmacists cannot test for or treat strep throat in children under six years old. The bill also updates the Oklahoma Pharmacy Act's definitions, specifically adding a new definition for "minor, nonchronic health condition" and modifying the definition of "practice of pharmacy" to include these new testing and treatment capabilities. The changes will take effect on November 1, 2025, providing pharmacists with an expanded role in providing accessible, immediate healthcare services for certain short-term, manageable health conditions.

Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=sb741&Session=2600